Home » Topics » BioWorld Science

BioWorld Science
RSS

Diffusion completes phase Ib study of TSC in hospitalized COVID-19 patients with hypoxemia

Feb. 17, 2021

CXCR7 as a novel therapeutic target for myocardial infarction

Feb. 17, 2021

Enfortumab vedotin shows promise for treating patients with advanced urothelial cancer

Feb. 17, 2021

Cell-penetrating peptides developed to target STAT3 for antitumor effects

Feb. 17, 2021

InteRNA initiates first-in-human study of INT-1B3 in advanced solid tumors

Feb. 16, 2021

Valbiotis gains French clearance to begin phase II study of TOTUM-070 to reduce LDL-cholesterol

Feb. 16, 2021

WHO lists two versions of AstraZeneca/Oxford COVID-19 vaccine for emergency use

Feb. 16, 2021

TLX-591-CDx for prostate cancer imaging receives first E.U. approval in Czech Republic

Feb. 16, 2021

Neuren reports phase I data on NNZ-2591 and plans to expand development into Prader-Willi syndrome

Feb. 16, 2021

FDA places partial clinical hold on atuzaginstat

Feb. 16, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...